金属-蛋白质混合材料:在生物医学应用中开启新的前沿
Yong Pan1, Han Zhao1, Wenyong Huang1
1Faculty of Chemistry, Northeast Normal University, Changchun, 130024, P.R. China.
Advanced healthcare materials
|January 8, 2025
概括
金属蛋白混合材料为各种应用提供可调节的性能. 本综述详细介绍了它们的设计,性能和生物医学用途,包括癌症治疗和药物输送.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 材料工程 材料工程 材料工程
背景情况:
- 金属蛋白混合材料是一种新的功能材料类.
- 它们具有特殊的物理化学特性和可调节的结构.
- 这些材料在材料工程,生物催化,生物传感和生物医学中具有广泛的应用.
研究的目的:
- 提供金属蛋白混合材料的全面分析.
- 专注于它们的设计策略,内在特性和生物医学应用.
- 评估它们在生物医学应用中的临床转化潜力.
主要方法:
- 对金属蛋白混合材料现有文献的综述.
- 设计策略和合成方法的分析.
- 评估生物医学应用和临床翻译潜力.
主要成果:
- 金属蛋白混合材料表现出显著的物理化学特性和可调节的结构.
- 理性设计使稳定混合材料的简单合成,并具有所需的功能.
- 这些材料在癌症治疗,药物/疫苗输送,抗菌治疗和组织再生方面具有显著的潜力.
结论:
- 金属蛋白混合材料为生物医学应用提供了多功能和生物相容的解决方案.
- 需要进一步的研究和开发来克服现有的局限性和挑战.
- 这些混合材料对临床翻译和在医疗保健中的实际实施具有前景.
相关概念视频
Proteomics
7.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.2K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K


